Keyphrases
Acute Respiratory Distress Syndrome
9%
Adenosine Diphosphate
27%
Adsorption
18%
Amyloid Protein
9%
Anticoagulant Therapy
16%
Antiplatelet Therapy
9%
Antithrombin III (ATIII)
14%
Apheresis
18%
C-Jun N-terminal Kinase
5%
Capillary
19%
Chemokine Ligand 12 (CXCL12)
11%
Collagen
35%
Collagen-induced
18%
Critically Ill Patients
13%
Diabetic Patients
5%
Endothelial Glycocalyx
41%
Endothelial Injury
5%
Endotoxemia
12%
Epigallocatechin Gallate
9%
Experimental Endotoxemia
11%
Generalized Pustular Psoriasis
14%
Glycocalyx
18%
Glycocalyx Injury
8%
Glycoprotein Ib-IX-V
8%
Granule Secretion
18%
Granulocyte Colony-stimulating Factor (G-CSF)
8%
Granulocytes
18%
Heat Shock Protein 27 (HSP27)
58%
Hemodiafiltration
8%
Hospital Days
7%
HSP27 Phosphorylation
31%
HSPB1
9%
Human Platelets
100%
Induced Activation
5%
Inflammation
6%
Interleukin-6
6%
Ligand Release
21%
Lipopolysaccharide
13%
Lung
6%
Major Trauma
9%
Mitogen-activated Protein Kinase
24%
Monocytes
18%
Multiple Organ Failure
5%
Negatively Regulate
5%
NSC23766
7%
Osteoblast
13%
P38 MAP Kinase
6%
P38 Mitogen-activated Protein Kinase (p38 MAPK)
30%
Patients with Diabetes Mellitus
5%
Phosphorylation
45%
Platelet Activation
37%
Platelet Aggregation
22%
Platelet Granules
10%
Platelet-derived Growth factor-BB (PDGF-BB)
32%
Platelets
20%
Pulmonary Capillaries
7%
Recombinant Antithrombin
6%
Retrospective Cohort Study
19%
Retrospective Observational Study
5%
Rho Kinase
18%
Ristocetin
20%
Sepsis
9%
Snowboarding
5%
Soluble CD40 Ligand
42%
Syndecan-1
29%
Synergistic Effect
5%
Three-dimensional (3D)
6%
Thrombin Receptor
14%
Thrombomodulin
10%
Thrombosis
6%
Thromboxane A2 (TXA2)
23%
Trauma
9%
Type 2 Diabetes Mellitus Patients
5%
U46619
9%
Ultrastructure
10%
University Hospital
7%
Vascular Endothelial Dysfunction
7%
αB-crystallin
9%
Pharmacology, Toxicology and Pharmaceutical Science
15 Hydroxy 11alpha,9alpha Epoxymethanoprosta 5,13 Dienoic Acid
8%
4 Amino 6 [2 [[4 (Diethylamino) 1 Methylbutyl]amino] 6 Methyl 4 Pyrimidinyl] 2 Methylquinoline
6%
Adenosine Diphosphate
23%
Adult Respiratory Distress Syndrome
10%
Anticoagulant Agent
11%
Antiplatelet
7%
Antithrombin III
9%
Antithrombocytic Agent
5%
Biological Marker
5%
CD40 Ligand
29%
Cohort Study
9%
Diabetes Mellitus
5%
Disease
6%
Endothelium Injury
8%
Endotoxemia
7%
Epigallocatechin Gallate
9%
Experimental Endotoxemia
9%
Glycoprotein Ib
9%
Heat Shock Protein 27
51%
Hemodialysis
6%
Injury
20%
Interleukin 6
7%
Lipopolysaccharide
10%
Mitogen Activated Protein Kinase 1
16%
Mitogen Activated Protein Kinase P38
29%
Multiple Organ Failure
5%
Non Insulin Dependent Diabetes Mellitus
5%
Phosphotransferase
5%
Platelet Derived Growth Factor AB
19%
Polyphenol
5%
Pustular Psoriasis
5%
Recombinant Thrombomodulin
9%
Rho Kinase
18%
Ristocetin
20%
Sepsis
9%
Syndecan 1
24%
Thrombomodulin
9%
Thromboxane A2
23%
Medicine and Dentistry
Amyloid Protein
9%
Anticoagulant Therapy
15%
Antiplatelet
9%
Apheresis
18%
Bleeding
9%
Case Presentation
7%
Computer Assisted Tomography
8%
Disease
5%
Generalized Pustular Psoriasis
14%
Granulocyte
18%
Heat Shock Protein 27
6%
Hemodiafiltration
8%
Injury
26%
Lactic Acidosis
5%
Platelet
10%
Retrospective Cohort Study
18%
Syndecan 1
9%
Thrombin Receptor
9%
Thrombocyte Activation
9%